From A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it.

In an experiment involving 32 breast cancer survivors, a 45-minute session of either resistance training or high-intensity ...

ProteinQure's PQ203, a novel peptide drug conjugate, gains FDA fast track designation for advanced triple-negative breast ...

An anti-nausea drug may reduce recurrence and death in aggressive breast cancer. Scientists are exploring its broader use in ...

This report details how pleomorphic breast carcinoma evaded initial treatment protocols and spread to 70% of the thorax within months.

Significant advances in breast cancer treatments have improved outcomes, offering personalized care through innovative ...

A novel AI tool could help clinicians personalize cancer treatments through characterization of individual tumor ...

Atezolizumab enhances long-term outcomes in triple-negative breast cancer, revealing promising insights on ctDNA as a ...

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple ...

Spanish researchers have achieved a significant breakthrough in the fight against the deadliest form of breast ...

Breast cancer is the most common cancer in women in the U.S., with the exception of skin cancers, according to the American Cancer Society.